Powering
Smarter Treatments and Healthier People 

Managing clinical research demands more than disconnected systems; it requires an intelligent platform that links Study, Patient, and Data Experiences.

Why Experiences

Discover how early AI adoption is transforming every stage of the trial lifecycle in our 2nd annual State of AI in Clinical Trials report.

Why Medidata

Chosen Technology

0 %

of FDA novel drug
approvals used Medidata

in 2025

TRUSTED IN

0 K+

clinical trials

AI FOR IMPACT BUILT ON

0 B

data points annually

USED BY

0 M+

patients

Results Proven at Scale
across Therapeutic Areas, Sponsors, and CROs.

Real Impact across Every Role

Data

 
Video thumbnail

ICON Harmonizes Clinical Risk Management, Data Management, and Medical Review teams through Clinical Data Studio

There are cost reductions, and we’re able to expedite timelines. We’re getting listings live at first-patient-in. We’re getting triangular review done—we’re getting manual review done faster.

Luke Gregory

Senior Director, Clinical Systems

Awards and Recognition

The Latest

New. Now. Noteworthy.
Discover the breakthroughs shaping what's next.

Go to Newsroom

R&G PharmaStudies Expands Partnership with Medidata, Deploying the Medidata Data Experience to Elevate Trial Quality and Accelerate Global Therapies

Medidata Champions Collaborative Scientific Advancement at ASCO with New Research on Oncology Protocol Optimization and CAR T Efficacy

Medidata’s Next-Gen AI Imaging Solution Delivers Unprecedented Speed and Precision for Clinical Trials

Medidata’s Second Annual AI Report Shows a Shift from Pilots to Enterprise Adoption with 72.9% of Early Adopters Seeing a Reduction in Study Timelines